Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce479583e3554367dd4a81269b4a3a67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb8dfbdb60b4701b90e8080b26235117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78740286a972c16255b9398365515bca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-06008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate |
2012-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eed39a6fc17aab20d5f8a68265c7afa5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e366dd53c6f125da4c8b77a45f511b37 |
publicationDate |
2013-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2013081706-A1 |
titleOfInvention |
Methods and compositions for increasing arylsulfatase a activity in the cns |
abstract |
Provided herein are methods and compositions for treating a subject suffering from a deficiency in arylsulfatase A in the CNS. The methods include systemic administration of a bifunctional fusion antibody comprising an antibody to a human insulin receptor and an arylsulfatase A. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10538589-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9567400-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019157224-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3233922-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512145-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015031673-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155631-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11028156-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9975955-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10202467-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3954393-A1 |
priorityDate |
2011-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |